Close Menu

NEW YORK (360Dx) – Abbott announced today that its High Sensitive Troponin-I blood test has been CE marked.

The test is now available for use on the company's Architect system for cardiac risk assessment in countries that recognize the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.